Immunoadjuvant efficacy of plasmids with multiple copies of a CpG motif coadministrated with avian influenza vaccine in chickens

Vaccine

Volumn 29, Issue 29-30, 2011, Pages 4668-4675

  Hung, Li Hsiang ^a,b   Tsai, Pei Chun ^a   Wang, Ching Ho ^c   Li, Shiang Lin ^a   Huang, Chin Cheng ^d   Lien, Yi Yang ^a   Chaung, Hso Chi ^a  

^a NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b Kaohsiung Biological Product Co Ltd   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d FISHERIES RESEARCH INSTITUTE   (Taiwan)

Author keywords

Avian influenza; Chicken; CpG motif; Interferon; Toll like receptor

Indexed keywords

ALPHA INTERFERON; AVIAN INFLUENZA VACCINE; BETA ACTIN; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; MESSENGER RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 21; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AVIAN INFLUENZA; CELL PROLIFERATION; CHICKEN; CONTROLLED STUDY; COPY NUMBER VARIATION; CPG ISLAND; DRUG EFFICACY; DRUG POTENCY; HEMAGGLUTINATION INHIBITION; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA VIRUS A H5N2; INOCULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; SURVIVAL RATE; VIRUS STRAIN; VIRUS VIRULENCE;

EID: 79960642447     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.04.104     Document Type: Article

References (41)

1. Capua I, Alexander DJ. Avian influenza and human health. Acta Trop 2002;83:1-6.
2. Claas EC, Osterhaus AD, Beek R, De Jong JC, Rimmelzwaan GF, Senne DA, et al. Hunan influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancer 1998;351:472-7.
3. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998;279:393-6.
4. Krieg AM. Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides. Biochim Biophys Acta 1999;1489:107-16.
5. Adamsson J, Lindblad M, Lundqvist A, Kelly D, Holmgren J, Harandi AM. Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera toxin. J Immunol 2006;176:4902-13.
6. Chaung HC. CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy. Int Immunopharmacol 2006;6(10):1586-96.
7. Vleugels B, Ververken C, Goddeeris BM. Stimulatory effect of CpG sequences on humoral response in chickens. Poult Sci 2002;81(9):1317-21.
8. Ameiss KA, El Attrache J, Barri A, McElroy AP, Caldwell DJ. Influence of orally administered CpG-ODNs on the humoral response to bovine serum albumin (BSA) in chickens. Vet Immunol Immunopathol 2006;110(3-4):257-67.
9. Gomis S, Babiuk L, Godson DL, Allan B, Thrush T, Townsend H, et al. Protection of chickens against Escherichia coli infections by DNA containing CpG motifs. Infect Immun 2003;71(2):857-63.
10. He H, Lowry VK, Swaggerty CL, Ferro PJ, Kogut MH. In vitro activation of chicken leukocytes and in vivo protection against Salmonella enteritidis organ invasion and peritoneal S. enteritidis infection-induced mortality in neonatal chickens by immunostimulatory CpG oligodeoxynucleotide. FEMS Immunol Med Microbiol 2005;43(1):81-9.
11. He H, Genovese KJ, Swaggerty CL, Nisbet DJ, Kogut MH. In vivo priming heterophil innate immune functions and increasing resistance to Salmonella enteritidis infection in neonatal chickens by immune stimulatory CpG oligodeoxynucleotides. Vet Immunol Immunopathol 2007;117(3-4):275-83.
12. Mackinnon KM, He H, Swaggerty CL, McReynolds JL, Genovese KJ, Duke SE, et al. In ovo treatment with CpG oligodeoxynucleotides decreases colonization of Salmonella enteriditis in broiler chickens. Vet Immunol Immunopathol 2009;127(3-4):371-5.
13. Wang X, Jiang P, Deen S, Wu J, Liu X, Xu J. Efficacy of DNA vaccines against infectious bursal disease virus in chickens enhanced by coadministration with CpG oligodeoxynucleotide. Avian Dis 2003;47(4):1305-12.
14. Mahmood MS, Siddique M, Hussain I, Khan A, Mansoor MK. Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of highly virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide. Vaccine 2006;24(22):4838-46.
15. Zhang L, Tian X, Zhou F. Vaccination with Newcastle disease vaccine and CpG oligodeoxynucleotides induces specific immunity and protection against Newcastle disease virus in SPF chicken. Vet Immunol Immunopathol 2007;115(3-4):216-22.
16. Zhang L, Zhang M, Li J, Cao T, Tian X, Zhou F. Enhancement of mucosal immune responses by intranasal co-delivery of Newcastle disease vaccine plus CpG oligonucleotide in SPF chickens in vivo. Res Vet Sci 2008;85(3):495-502.
17. Zhang X, Yu Q, Zhang X, Yang Q. Co-administration of inactivated avian influenza virus with CpG or rIL-2 strongly enhances the local immune response after intranasal immunization in chicken. Vaccine 2009;27(41):5628-32.
18. Wang Y, Shan C, Ming S, Liu Y, Du Y, Jiang G. Immunoadjuvant effects of bacterial genomic DNA and CpG oligodeoxynucleotides on avian influenza virus subtype H5N1 inactivated oil emulsion vaccine in chicken. Res Vet Sci 2009;86(3):399-405.
19. Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunology Letters 2003;85(2):85-95.
20. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000;408(6813):740-5.
21. Boyd A, Philbin VJ, Smith AL. Conserved and distinct aspects of the avian Tolllike receptor (TLR) system: implications for transmission and control of birdborne zoonoses. Biochem Soc Trans 2007;35:1504-7.
22. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29(9):e45.
23. Lee CW, Senne DA, Suarez DL. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 2004;78(15):8372-81.
24. Rankin R, Pontarollo R, Ioannou X, Krieg AM, Hecker R, Babiuk LA, et al. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev 2001;11(5):333-40.
25. Taghavi A, Allan B, Mutwiri G, Van Kessel A, Willson P, Babiuk L, et al. Protection of neonatal broiler chicks against Salmonella Typhimurium septicemia by DNA containing CpG motifs. Avian Dis 2008;52(3):398-406.
26. Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, Akira S, et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A 2001;98:9237-42.
27. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000;406(6797):782-7.
28. Beutler BA. TLRs and innate immunity. Blood 2009;113:1399-407.
29. Kumagai Y, Takeuchi O, Akira S. TLR9 as a key receptor for the recognition of DNA. Adv Drug Deliv Rev 2008;60(7):795-804.
30. Brownlie R, Allan B. Avian toll-like receptors. Cell Tissue Res. 2010 Sep 1 [Epub ahead of print].
31. Keestra AM, de Zoete MR, Bouwman LI, van Putten JP. Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9. J Immunol 2010;185(1):460-7.
32. Roach JC, Boysen C, Wang K, Hood L. Pairwise end sequencing: a unified approach to genomic mapping and sequencing. Genomics 1995;26(2):345-53.
33. Iqbal M, Philbin VJ, Smith AL. Expression patterns of chicken Toll-like receptor mRNA in tissues, immune cell subsets and cell lines. Vet Immunol Immunopathol 2005;104(1-2):117-27.
34. Yilmaz A, Shen S, Adelson DL, Xavier S, Zhu JJ. Identification and sequence analysis of chicken Toll-like receptors. Immunogenetics 2005;56(10):743-53.
35. He H, Crippen TL, Farnell MB, Kogut MH. Identification of CpG oligodeoxynucleotide motifs that stimulate nitric oxide and cytokine production in avian macrophage and peripheral blood mononuclear cells. Dev Comp Immunol 2003;27(6-7):621-7.
36. Wattrang E. Phosphorothioate oligodeoxyribonucleotides induce in vitro proliferation of chicken B-cells. Vet Immunol Immunopathol 2009;131(3-4):218-28.
37. Chaung HC, Chen CW, Hsieh BL, Chung WB. Toll-like receptor expressions in porcine alveolar macrophages and dendritic cells in responding to poly IC stimulation and porcine reproductive and respiratory syndrome virus (PRRSV) infection. Comp Immun Micro Infect Dis 2010;33(3):197-213.
38. Cox JC, Coulter AR. Adjuvants-a classification and review of their modes of action. Vaccine 1997;15(3):248-56.
39. Hartmann G, Weiner GJ, Krieg AM. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci U S A 1999;96:9305-10.
40. Kojima Y, Xin KQ, Ooki T, Hamajima K, Oikawa T, Shinoda K, et al. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine. Vaccine 2002;20(23-24):2857-65.
41. Yoshikawa T, Imazu S, Gao JQ, Hayashi K, Tsuda Y, Okada N, et al. Non-methylated CpG motif packaged into fusogenic liposomes enhance antigen-specific immunity in mice. Biol Pharm Bull 2006;29:105-9.